SCHEMBL31200582

SCHEMBL31200582

COc1ccc(B2OC(C)(C)C(C)(C)O2)c(O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SNCA P37840 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ TRIM24 O15164 1/20 0.41
▸ TYR P14679 1/20 0.41
▸ TRIM33 Q9UPN9 1/20 0.41
▸ UCHL1 P09936 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26117053 1.00 NPC1 (0.42) NPC1RAB9ASNCAALDH1A1CYP3A4
SCHEMBL4521109 0.87 ALDH1A1 (0.43) NPC1RAB9ASNCAALDH1A1CYP3A4
SCHEMBL5477046 0.82 LPL (0.35) TYRCA1CA2CA9
SCHEMBL28961843 0.81 CXCR2 (0.42) UCHL1CA1CA2CA9HIF1A
SCHEMBL31114631 0.81 CXCR2 (0.42) UCHL1CA1CA2CA9HIF1A
SCHEMBL31034978 0.81 CA1 (0.36) ALDH1A1UCHL1CA1CA2CA9
SCHEMBL5899720 0.81 CA2 (0.47) SNCAALDH1A1CYP3A4HPGDUCHL1
SCHEMBL7162404 0.81 SNCA (0.42) SNCAALDH1A1CYP3A4HPGDUCHL1
SCHEMBL29424578 0.81 CA2 (0.47) SNCAALDH1A1CYP3A4HPGDUCHL1
SCHEMBL16553305 0.80 SNCA (0.41) NPC1RAB9ASNCAALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680601-A1 PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES Sanofi (FR) 2026-01-21 — — EP disclosed
WO-2024188994-A1 PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES SANOFI (FR) 2024-09-19 — — WO disclosed
Send feedback